THE WOOF OF WALL STREET

[JUST WAITING]

NPHC 0009 READ Nutra Pharma has a solution and its FDA Registered and works!!! It's time for Federal and State government agencies to get with the program. This crisis is not going away. Soon the crisis will have political impacts in elections. The alternative pipeline you will note in the article below is THIN. There are few solutions and approaches. NPHC is a Market Cap play with 21 patents, figure Nutra Pharma gets 1% Market Share for alternatives to the opiate crisis. I will let everyone here do their own math! I guarantee it is much much higher than 1 million.

Job now is to get the alternative opioid solution out to folks that really need it which is in the millions of people not to mention our "Orphan Drug Status" for our Pediatric MS solutions. There are kids with MS that need this as well. Crucial folks !!!

November 3, 2017

https://www.xconomy.com/national/2017/11/03/biotech-roundup-opioid-news-ash-preview-boston-bio-ipos-more/

The rising death toll from opioids has prompted policymakers to try various ways to take on the problem. President Trump’s opioid commission released its final report this week, calling for expansion of drug courts, better physician training, and penalties for insurers that don’t cover treatment.

But the commission did not say how much its recommendations would cost, nor did it offer a way to pay for them. The absence of those details highlight the difficulties in addressing the crisis. One option is offering other, non-addictive medications. But as an Xconomy report noted, the pipeline of alternatives is thin due to various challenges developing new pain drugs. Some officials are pursuing legal remedies. New Jersey sued Stamford, CT-based Purdue Pharma, pinning blame for the state’s opioid crisis on the drug maker’s marketing tactics to doctors and patients.